169 related articles for article (PubMed ID: 21058943)
1. Replication of GWAS associations for GAK and MAPT in Parkinson's disease.
Rhodes SL; Sinsheimer JS; Bordelon Y; Bronstein JM; Ritz B
Ann Hum Genet; 2011 Mar; 75(2):195-200. PubMed ID: 21058943
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study confirms extant PD risk loci among the Dutch.
Simón-Sánchez J; van Hilten JJ; van de Warrenburg B; Post B; Berendse HW; Arepalli S; Hernandez DG; de Bie RM; Velseboer D; Scheffer H; Bloem B; van Dijk KD; Rivadeneira F; Hofman A; Uitterlinden AG; Rizzu P; Bochdanovits Z; Singleton AB; Heutink P
Eur J Hum Genet; 2011 Jun; 19(6):655-61. PubMed ID: 21248740
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.
Dumitriu A; Pacheco CD; Wilk JB; Strathearn KE; Latourelle JC; Goldwurm S; Pezzoli G; Rochet JC; Lindquist S; Myers RH
Hum Mol Genet; 2011 Apr; 20(8):1478-87. PubMed ID: 21258085
[TBL] [Abstract][Full Text] [Related]
4. Genomewide association study for susceptibility genes contributing to familial Parkinson disease.
Pankratz N; Wilk JB; Latourelle JC; DeStefano AL; Halter C; Pugh EW; Doheny KF; Gusella JF; Nichols WC; Foroud T; Myers RH;
Hum Genet; 2009 Jan; 124(6):593-605. PubMed ID: 18985386
[TBL] [Abstract][Full Text] [Related]
5. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
[TBL] [Abstract][Full Text] [Related]
6. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the association between GAK rs1564282 C/T polymorphism and the risk of Parkinson's disease.
Ma ZG; He F; Xu J
J Clin Neurosci; 2015 Jul; 22(7):1077-80. PubMed ID: 25975492
[TBL] [Abstract][Full Text] [Related]
8. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
[TBL] [Abstract][Full Text] [Related]
9. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
[TBL] [Abstract][Full Text] [Related]
10. Reaffirmation of GAK, but not HLA-DRA, as a Parkinson's disease susceptibility gene in a Taiwanese population.
Lin CH; Chen ML; Tai YC; Yu CY; Wu RM
Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):841-6. PubMed ID: 24039160
[TBL] [Abstract][Full Text] [Related]
11. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
[TBL] [Abstract][Full Text] [Related]
12. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
[TBL] [Abstract][Full Text] [Related]
14. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
15. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.
Edwards TL; Scott WK; Almonte C; Burt A; Powell EH; Beecham GW; Wang L; Züchner S; Konidari I; Wang G; Singer C; Nahab F; Scott B; Stajich JM; Pericak-Vance M; Haines J; Vance JM; Martin ER
Ann Hum Genet; 2010 Mar; 74(2):97-109. PubMed ID: 20070850
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.
Chung SJ; Armasu SM; Anderson KJ; Biernacka JM; Lesnick TG; Rider DN; Cunningham JM; Ahlskog JE; Frigerio R; Maraganore DM
Parkinsonism Relat Disord; 2013 Jun; 19(6):595-9. PubMed ID: 23507417
[TBL] [Abstract][Full Text] [Related]
18. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
[TBL] [Abstract][Full Text] [Related]
19. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
